ENHANCED SILK PROTEIN MATERIAL HAVING IMPROVED MECHANICAL PERFORMANCE AND METHOD OF FORMING THE SAME
    1.
    发明申请
    ENHANCED SILK PROTEIN MATERIAL HAVING IMPROVED MECHANICAL PERFORMANCE AND METHOD OF FORMING THE SAME 审中-公开
    具有改进的机械性能的增强的丝素蛋白质材料及其形成方法

    公开(公告)号:US20100068517A1

    公开(公告)日:2010-03-18

    申请号:US12441114

    申请日:2007-09-12

    IPC分类号: B32B1/00 H05F3/00 C07K14/435

    摘要: The invention provides an enhanced silk fiber rivaling spider silk in mechanical performance, in combination with a very low-cost method for producing it from the usual silkworms. The method provides for the simple application of an electric field which results in an enhancement of over (?) 40% in the strength, and of 200% in the breaking energy with respect to ordinary silkworm silk. The critical elasticity is enhanced to the level of the dragline spider silk. The provided enhanced silk protein material has the same protein primary structure, fiber diameter and length of the customary silk. The method of formation offers the following advantages in comparison to other methods available in the prior art. Industrial scale production can be readily and cost-effectively achieved, given the wide-range availability of silkworms. The provided method relies largely on the present standard production processes of silkworm silk, and hence a low level of investment is required. Since no additional chemicals are required, the provided method is environmentally friendly.

    摘要翻译: 本发明提供了一种增强的蚕丝纤维与机械性能相抗衡的蜘蛛丝,结合从普通蚕生产它的非常低成本的方法。 该方法提供电场的简单应用,其导致相对于普通蚕丝的强度超过(≥)40%,断裂能量增加200%。 临界弹性提高到牵引蜘蛛丝的水平。 提供的增强的丝蛋白材料具有与常规丝绸相同的蛋白质一级结构,纤维直径和长度。 与现有技术中可用的其它方法相比,形成方法具有以下优点。 鉴于家蚕的广泛使用,工业规模的生产可以容易和经济有效地实现。 提供的方法在很大程度上取决于蚕丝的现行标准生产工艺,因此需要较低的投资。 由于不需要额外的化学物质,所提供的方法是环保的。

    USE OF SOPHORICOSIDE IN THE MANUFACTURE OF MEDICAMENTS
    3.
    发明申请
    USE OF SOPHORICOSIDE IN THE MANUFACTURE OF MEDICAMENTS 审中-公开
    在药物制造中使用异佛尔酮

    公开(公告)号:US20110130355A1

    公开(公告)日:2011-06-02

    申请号:US13056262

    申请日:2009-08-06

    申请人: Ning Du

    发明人: Ning Du

    CPC分类号: A61K31/7048

    摘要: The present invention relates to the use of sophoricoside for the prevention and/or the treatment of articular cartilage degeneration or osteoarthritis in post-menopausal women. It is effective and has no side-effects on uterus, breasts and the like as animal-derived estrogen does. It is easy to be extracted and the source thereof is abundant. Therefore, it has a promising marketing prospect.

    摘要翻译: 本发明涉及槐花苷用于预防和/或治疗绝经后妇女关节软骨变性或骨关节炎的用途。 对动物来源的雌激素的子宫,乳房等没有副作用。 易于提取,其来源丰富。 因此,它具有广阔的市场前景。